EDAP Reports First Quarter 2022 Results
May 17, 2022 16:35 ET
|
EDAP TMS S.A.
First quarter 2022 revenue of approximately EUR 13.0 million (USD 14.5 million), an increase of 26% as compared to EUR 10.3 million (USD 12.4 million) for the first quarter 2021Four Focal One units...
EDAP TMS SA to Announce First Quarter 2022 Financial Results on May 17, 2022
May 10, 2022 08:30 ET
|
EDAP TMS S.A.
Company to host conference call and webcast on, Wednesday, May 18th at 8:30 am EDT LYON, France, May 10, 2022 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies,...
EDAP to Showcase its Focal One® Platform at the Annual Meeting of the American Urological Association (AUA)
May 05, 2022 08:30 ET
|
EDAP TMS S.A.
AUA is the largest annual gathering of urologists worldwide LYON, France, May 5, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies,...
EDAP Provides Corporate Update on US Focal One® Installation Growth
April 12, 2022 08:00 ET
|
EDAP TMS S.A.
Company announces Focal One® placements at three renowned academic institutions in March LYON, France, April 12, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in...
EDAP Reports Fourth Quarter and Full Year 2021 Results
March 30, 2022 16:35 ET
|
EDAP TMS S.A.
Full year revenue of approximately EUR 44.1 million (USD 51.9 million) as compared to EUR 41.7 million (USD 47.8 million) for the full year 2020Full year US HIFU treatment volumes increased 65% over...
EDAP TMS SA to Announce Fourth Quarter 2021 Financial Results on Wednesday, March 30, 2022
March 21, 2022 08:00 ET
|
EDAP TMS S.A.
Company to host conference call and webcast on Thursday, March 31, at 8:30 am ET LYON, France, March 21, 2022 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today...
EDAP Issues Letter to Shareholders
February 01, 2022 08:00 ET
|
EDAP TMS S.A.
LYON, France, February 1, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today issued the following letter to shareholders: To my...
EDAP Announces Publication of Positive Pre-clinical Results Using Intraoperative HIFU Ablation of the Pancreas in the Journal Cancers
January 13, 2022 08:00 ET
|
EDAP TMS S.A.
Represents first step towards a potential clinical treatment of locally advanced pancreatic cancer LYON, France, January 13, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global...
EDAP Provides Corporate Update on US Focal One Installation Growth
January 05, 2022 08:00 ET
|
EDAP TMS S.A.
Company announces several key U.S. Focal One installations during Q4 LYON, France, January 5, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based...
EDAP to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 29, 2021 09:30 ET
|
EDAP TMS S.A.
LYON, France, November 29, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the company will participate in a fireside chat...